Validation of the cross-cultural dementia screening test in Alzheimer's disease and Parkinson's disease.

ABSTRACT:

Objective

The Cross-Cultural Dementia (CCD) is a new screening tool to evaluate cognitive impairment based on a cross-cultural perspective to reduce the bias of education, and language and cultural differences. We aimed to evaluate the diagnostic properties of the CCD in Spaniards for the assessment of patients with Alzheimer's disease in mild cognitive impairment (AD-MCI) and mild dementia stages (AD-D) and patients with mild cognitive impairment associated with Parkinson's disease (PD-MCI).

Methods

Sixty participants with AD (50% MCI) and thirty with PD-MCI were enrolled. Each clinical group was compared against a healthy control group (HC) with the same number of participants and no significant differences in age, education, and sex. A comprehensive neuropsychological tes

SUBMITTER: Delgado-Alvarez A 

PROVIDER: S-EPMC9846357 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature